Drug testing is now ubiquitous in sport, and it often falls to the team physician to perform a variety of roles including interpreting test results, designing drug-testing programs, acting as medical review officer, and providing therapeutic use exemptions, education, and counseling. Proper understanding of current testing methods for drugs such as anabolic-androgenic steroids, erythropoietin, and growth hormone is essential if the team physician is going to assume these positions. This article outlines the basics of athletic drug testing from the collection process through the interpretation of results to assist the team physician in this field.
Ayotte C. Significance of 19-norandrosterone in athlete’s urine samples. Br J Sports Med. 2006;40:25-29.
2.
Baume N, Avois L, Schweizer C, et al. [13C]Nandrolone excretion in trained athletes: interindividual variability in metabolism. Clin Chem. 2004;50:355-364.
3.
Breidbach A. Erythropoietin (EPO)/darbepoetin. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:431-433.
4.
Catlin DH, Ahrens B, Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes’ urine. Rapid Commun Mass Spectrom. 2002;16:1273-1275.
5.
Catlin DH, Breidbach A, Elliott S, Glaspy J. Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human EPO, and endogenous EPO from human urine. Clin Chem. 2002;48: 2057-2059.
6.
Catlin DH, Hatton CK, Starcevic SH. Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athlete’s urine. Clin Chem. 1997;43:1280-1288.
7.
Catlin DH, Leder BZ, Ahrens B, et al. Trace contamination of over-thecounter androstenedione and positive urine test results for a nandrolone metabolite. JAMA. 2000;284:2618-2621.
8.
Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom. 2004;18:1245-1249.
9.
Donike M, Barwald KR, Klosterman K, et al. The detection of exogenous testosterone. In: Heck H, Hollmann W, Liesen H, Rost R, eds. Sport: Leistung und Gesundheit. Cologne, Germany: Deutscher Arzte Verlag; 1983: 293-300.
10.
Elliot DL, Goldberg L, Moe EL, Defrancesco CA, Durham MB, Hix Small H. Preventing substance use and disordered eating: initial outcomes of the ATHENA (Athletes Targeting Healthy Exercise and Nutrition Alternatives) program. Arch Pediatr Adolesc Med. 2004;158: 1043-1049.
11.
Goldberg L, Elliot DL, Clarke GN, et al. Effects of a multidimensional anabolic steroid prevention intervention: the Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA. 1996;276:1555-1562.
12.
Green GA. Anabolic agents. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006: 59-61.
13.
Green GA. Cannabinoids. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006: 208-209.
14.
Green GA. HGH/somatomedins. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006: 624-625.
15.
Green GA, Catlin DH, Starcevic B. Analysis of over-the-counter dietary supplements. Clin J Sport Med. 2001;11:254-259.
16.
Hatton CK. Carbon isotope ratio testing. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:216-218.
17.
Hatton CK. Nandrolone. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:900-901.
18.
Hoberman J. Sports physicians and the doping crisis in elite sport. Clin J Sport Med. 2002;12:203-208.
19.
Lasne F, De Ceaurriz J. Recombinant erythropoietin in urine. Nature.2000;405:635-635.
20.
Le Bizec B, Gaudin I, Monteau F, et al. Consequences of boar edible tissue consumption on urinary profiles of nandrolone metabolites. Rapid Commun Mass Spectrom. 2000;14:1058-1065.
21.
National Collegiate Athletic Association. National Collegiate Athletic Association 2005 Study of Substance Use Habits of College Student Athletes. Indianapolis, Ind: National Collegiate Athletic Association; 2006.
22.
Parisotto R, Wu M, Ashenden MJ, et al. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica. 2001;86:128-137.
23.
Schmitt N, Flament M, Goubault C, Legros P, Grenier-Loustalot MF, Denjean A. Nandrolone excretion is not increased by exhaustive exercise in trained athletes. Med Sci Sports Exerc. 2002;34:1436-1439.
24.
Sekera MH, Ahrens B, Chang YC, Starcevic B, Georgakopoulos C, Catlin DH. Another designer steroid: discovery, synthesis, and detection of “madol” in urine. Rapid Commun Mass Spectrom. 2005;19:781-784.
25.
Tokish JM, Kocher MS, Hawkins RJ. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med. 2004;32:1543-1553.
26.
UK Sport. Nandrolone progress report to the UK Sports Council from the Expert Committee on Nandrolone. Available at: www.uksport.gov.uk/images/uploaded/Nandrolone_Progress_Report_Feb03.pdf. Accessed September 3, 2003.
27.
Uryasz F. Chain of custody issues. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:255-256.
28.
Uryasz F. Collection issues. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:278-280.
29.
World Anti-doping Agency. International standard for therapeutic use exemptions. Available at: http://www.wada-ama.org/rtecontent/document/international_standard.pdf. Accessed December 22, 2005.
30.
World Anti-doping Agency. The 2006 prohibited list international standard. Available at: http://www.wada-ama.org/rtecontent/document/2006_LIST.pdf. Accessed December 22, 2005.
31.
World Anti-doping Agency. World anti-doping code. Available at: http://www.wada-ama.org/rtecontent/document/code_v3.pdf. Accessed January 9, 2006.
32.
Zida W, Bildingmaier M, Dall R, Strasburger CJ. Detection of doping with human growth hormone. Lancet. 1999;353:895-895.
